- Recovery From Drug and Alcohol Addiction By : Maureen Staiano
When in early recovery from drugs and alcohol it is important to have a realistic perspective of time. Unfortunately an addict's and alcoholic's concept time tends to be warped. This article covers some helpful advice regarding time and early recovery. - Substance Abuse Clinics By : Damian Sofsian
Substance abuse clinics like centers for detoxification are designed to treat both the psychological and physical aspects of drug-abusing patients These patients have suffered severe psychological and physical setbacks because of drug intake and the damage it has done to the brain and body chemistry. These clinics provide support and medical supervision during the first few days of treatment, since abstinence or withdrawal from an addicted substance can usually be physically consuming and dangerous. - Substance Abuse Treatments By : Damian Sofsian
Substance abuse is a treatable, and the appropriate treatment is crucial for drug abusers to reduce their drug use, improve their ability to function and minimize the medical and social complications. The goal for any person in treatment is to attain total recovery from substance abuse. - Drug Abuse Treatment Programs By : Kristy Annely
There are about 10,000 drug rehabilitation and treatment centers in the country today. And each one may use varying programs to deal with addiction. But generally, drug addiction treatments are grouped into three categories. - Substance Abuse By : Damian Sofsian
We live in a world where war against drug abuse is a continuous struggle. - Drug Abuse in the First World is Serious By : Lance Winslow
How bad is Drug Abuse in the United States of America? How can we stop abuse of drugs with our young people? Why is the war on drugs a lost cause? Is legalization of drugs the right solution? What will we do in the future as all these folks in their teens or still young adults hit their middle thirties and need new Heart Valves? - Hospital First To Describe New Statistical Method By : Drug Trials News
Statisticians at St. Jude Children's Research Hospital have developed a new technique that allows researchers to statistically analyze results of clinical trials. In it, all participants receive a new treatment and none are assigned to a control group getting the existing treatment. Instead, the treatment group is compared with a so-called “historical control” composed of patients who received the existing treatment in a previous study. - St. Jude First To Describe New Statistical Method By : Drug Trials News
Statisticians at St. Jude Children's Research Hospital have developed a new technique that allows researchers to statistically analyze results of clinical trials. In it, all participants receive a new treatment and none are assigned to a control group getting the existing treatment. Instead, the treatment group is compared with a so-called "historical control" composed of patients who received the existing treatment in a previous study. - Surveillance, Rapid Screening, And Hospital Hygiene Key To Preventing Future Transmission Of MRSA By : Drug Resistance News
The origins and future perspectives about meticillin-resistant Staphylococcus aureus (MRSA) are outlined in a review in this week's issue of THE LANCET. - Panacos Completes Pre-clinical Studies Indicating Bevirimat Is Non-Teratogenic By : Health News
Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the completion of preclinical studies indicating that their lead drug candidate, bevirimat (PA-457), is non-teratogenic, meaning it did not cause fetal malformations in the models used in the studies. - Depomed to Present at the ThinkEquity Partners Growth Conference By : Health News
Depomed, Inc. (NASDAQ:DEPO) today announced that chairman, president and chief executive officer, John W. Fara, Ph.D., will present on Wednesday, September 13, 2006 at 2:30 p.m. PT during the ThinkEquity Partners Growth Conference taking place in San Francisco. - Calgenex Corporation Founded to Address Problem of Soft Tissue Calcification By : Health News
Grant Carlson today announced the formation of Calgenex Corporation, a manufacturer and marketer of dietary supplements, topical over-the-counter (OTC) drugs, and personal care products specially formulated to combat the effects of soft tissue calcification and inflammation. Calgenex is one of the only companies in the world to address this pervasive yet often ignored medical condition. - Extremely Deadly Tuberculosis Strain Appears In South Africa By : Drug Resistance News
An extremely deadly strain of Tuberculosis has appeared in South Africa, killing 52 of 53 people diagnosed with it so far. It is called XDR-TB (Extreme Drug Resistant Tuberculosis). Officials say it started in rural areas of the Kwazulu-Natal region of the country among miners, and has probably found its way into urban areas. - PhytoMedical Announces Addition of Proven Industry Executive By : Health News
PhytoMedical Technologies, Inc. (OTCBB:PYTO) (FWB:ET6) today announced the addition of James F. Lynch, PhD, MBA, President of Strategic Access, Inc., to its Scientific Advisory Board. - The Importance of Drug and Alcohol Rehab By : John Stoops
- Schering-Plough Announces FDA Approval Of NOXAFIL(R) (Posaconazole) For Prevention By : Drug Resistance News
Schering-Plough Corporation (NYSE: SGP) today reported that the U.S. Food and Drug Administration (FDA) has approved NOXAFIL(R) (posaconazole) Oral Suspension for prophylaxis (prevention) of invasive Aspergillus and Candida infections in patients 13 years of age and older who are at high risk of developing these infections due to being severely immunocompromised. - UCLA Neuroscience Research Leads To A Possible Treatment For Type 1 Diabetes By : Drug Trials News
A new vaccine being tested in a human clinical trial holds a great deal of promise for treating type 1 diabetes, a disease that newly afflicts 35,000 children each year. The research that established the foundation for this vaccine was conducted in UCLA research laboratories. The drug is still being tested and is not likely to be available for at least a few years. - The Terrifying Link between Alcohol and Hypoglycemia By : K. Newton
- The Effects Of Smoking And Alcohol On Your Skin By : Misty McDowell
Although only very few people can actually have the perfect skin and complexion, we can do something to bring out the best in our skin. - Dobbs To Give Plenary Keynote At Drug Information Association Conference In Philadelphia, Sept. 26 By : Conferences News
Dr. Joel H. Dobbs, Executive-in-Residence and Program Director, Pharmaceutical Management, at Stevens Institute of Technology's Howe School, will deliver the plenary keynote address, "Four Questions about Pharma's Future (and Yours)," Tues., Sept. 26, at the Drug Information Association Conference, located at the Sheraton Philadelphia City Center, Philadelphia, Penn. (Please visit http://www.diahome.org/DIAHome/Home.aspx) - Alcoholism-An Unwanted Epidemic By : Eric Funston
Alcohol intoxication is the most important factor for a brain disorder in US alone. In the United States around 20 Million people including adolescents are suffering from some serious alcohol related problems. It is the second most dangerous factor of premature death after Cancer. - World-Wide Warning Of Highly Drug-Resistant Tuberculosis By : Drug Resistance News
The authors say that urgent action is needed to implement effective tuberculosis control strategies, especially in countries where tuberculosis control practices have been inadequate. - How To Stop Marijuana Cravings By : Gary Paul Evans
Would you be interested in learning how to give up smoking marijuana with little or no effort required? Cravings to smoke weed can seem irresistable, however there are scientific methods to prevent cravings of all kinds especially for marijuana addicts. - DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD By : Health News
DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company"), announced today that it has submitted in the Electronic Common Technical Document format a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") to market orBec(R) (oral beclomethasone dipropionate) for the treatment of gastrointestinal Graft-versus-Host disease ("GI GVHD") - Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma By : Health News
Alcon, Inc. (NYSE:ACL) announced today that the U.S. Food and Drug Administration (FDA) has approved TRAVATAN(R) Z (travoprost ophthalmic solution) 0.004% for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, who are intolerant of or insufficiently responsive to other intraocular pressure lowering medications. - Resistant Bacteria Increasing Source Of Muscle Infection By : Drug Resistance News
An antibiotic-resistant bacteria called methicillin-resistant Staphylococcus aureus (MRSA) is increasingly a cause of muscle infections in children, said Baylor College of Medicine (BCM) researchers in a report in the journal Clinical Infectious Diseases. - Living With An Alcoholic Spouse: A Healthy Detachment By : Angie Lewis
You are powerless to getting your loved one to stop drinking. The first step in being able to detach is by realizing that the shenanigans of the alcoholic is not your problem. Don’t try and fix their messes for them. Not only does this enable them to continue drinking, but also it justifies their drinking. Don’t have any interaction with the alcoholic while they are drinking; that includes, talking and arguing with them. Why fuss and fight with someone who has lost the ability to make any sense? - Acorda Announces Positive Phase 3 Fampridine-SR Study In People With Multiple Sclerosis By : Drug Trials News
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced positive results from its Phase 3 clinical trial of Fampridine-SR on walking in people with multiple sclerosis (MS). Statistical significance was achieved on all three efficacy criteria defined in the Special Protocol Assessment (SPA) by the Food and Drug Administration (FDA). - Trends In 'Superbug' Screening Identify Most Likely Carriers Of Deadly Bacteria In Hospital Settings By : Drug Resistance News
Findings released today from a new study at the American Society for Microbiology's 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC(TM)) provide doctors with a more complete epidemiologic picture of high-risk groups most likely to carry deadly organisms. - Harvard Researchers Recognize S.C. BlueCross Initiative to Make Prescription Comparisons Easier By : Health News
Harvard Medical School’s Department of Health Care Policy has selected BlueCross BlueShield of South Carolina’s My Pharmacy ManagerSM† for honors this week. The program was chosen for its approach to helping consumers tackle the challenge of comparing prescription medicine costs. - Do You Need Alcohol Treatment? By : Tim Sebastian
Alcohol is a drug, pure and simple. But the way if affects people is quite different. Statistics indicate that one out of every 10 folks is alcoholic, or at the very least, has drink problem. So consuming lots of booze on a regular basis does not necessarily get you hooked. - Investigational Antibiotic Ceftobiprole Shows Promise Against Potentially Life-Threatening MRSA By : Drug Resistance News
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. today announced that ceftobiprole, a novel cephalosporin(1) antibiotic in Phase III clinical trials, was found to be active against complicated skin infections caused by common, potentially deadly bacteria, including MRSA. These data were from two poster presentations given at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). - Viral Suppression in Triple-Class Drug Resistant Patients Maintained after 24 Weeks of Treatment By : Health News
Greater antiretroviral suppression was maintained after 24 weeks of therapy with MK-0518i, an investigational oral HIV integrase inhibitor in combination with optimized background therapy (OBT) versus placebo plus OBT in HIV-infected patients who failed antiretroviral therapy (ART) and who were resistant to drugs in all three classes of oral antiretroviral drugs. - Paratek Pharmaceuticals Presents New Preclinical Data On Novel Aminomethylcycline Antibiotic By : Drug Resistance News
Paratek Pharmaceuticals, Inc. announced today that it presented new preclinical data on MK-2764 (formerly PTK 0796), a novel broad spectrum aminomethylcycline antibiotic derived from the tetracycline class, at the 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) last week. - Pandemic Risk Increases – Anti Virals Losing Effectiveness, According to Firestorm Solutions By : Health News
Firestorm Solutions, LLC’s president, Jim Satterfield, jsatterfield@firestorm.com, cautioned today “In light of the World Health Organization (WHO) announcement that the two most prevalent anti-viral drugs are losing their effectiveness against the avian flu, pandemic response plans must be reviewed and updated.” - Flu Shots Available at Walgreens Beginning Oct. 2 By : Health News
Walgreens will offer more than 6,000 in-store flu and pneumonia vaccination clinics during its annual program Oct. 2 through Nov. 17. No appointment is necessary for vaccinations. - Landmark Five-Year Data on Gilead’s Anti-HIV Drug Viread® Presented at 8TH International Workshop By : Health News
Gilead Sciences, Inc. (Nasdaq: GILD) today announced two presentations of long-term efficacy and safety data from Study 903E on the company’s leading once-daily anti-HIV medication, Viread® (tenofovir disoproxil fumarate). - Causes and Effects of Youth Cocaine Abuse By : Jonathon Hardcastle
One of the biggest problems professionals have to encounter when dealing with drug abuse patients is the phenomenon of youth cocaine addicts. Parents, grandparents, school teachers, and family friends, are actually the most intimate group of people whose sphere of attention a kid or a teenager has to surpass - Living With An Alcoholic By : John McMahon
This article lists some behaviours to avoid when living with an alcoholic. You can't make a an alcoholic stop drinking however some behaviours can make the problem worse. - Sierra Health Services Announces Continued Participation in Medicare Prescription Drug Program By : Health News
Sierra Health Services, Inc. (NYSE:SIE) announced today that its wholly owned subsidiaries, Sierra Health and Life Insurance Company, Inc. (SHL) and Health Plan of Nevada, Inc. (HPN), have been selected by the Centers for Medicare & Medicaid Services (CMS) to participate for 2007 in the stand-alone prescription drug plan (PDP), Medicare Advantage HMO, Local and Regional PPO programs, and the Medicare Advantage Private Fee-For-Service (PFFS) program. - Alfacell Completes Non-Clinical Section of Rolling NDA for Lead Anticancer Drug ONCONASE® By : Health News
Alfacell Corporation (NASDAQ: ACEL) today announced that the company has completed the non-clinical section of the rolling submission of a New Drug Application (NDA) in preparation for its submission to the U.S. Food and Drug Administration (FDA) for its lead anticancer compound, ONCONASE (ranpirnase). - How to Reduce Drug Addiction Among Young People By : Mary Anne Winslow
The US government fails to realize the message it can send to young people in regard to drug abuse. In today's time, drugs has become something that is accepted because the government remains silent. When we (especially people in authority) constantly speak out against things that are illegal, we re-iterate in young people's minds that it is not acceptable. By speaking out, we send the message that we will not tolerate - An Effective 12 Step Program By : Morgan Hamilton
I know that observing something, even first hand, has nothing to do with going through it yourself, but still I have admired the inner power and will of a very close person who went through all the 12 steps of an addiction recovery program. - Searching For Cheap Drug And Alcohol Rehab Centers? By : Ras Reed
This articles briefly highlights how you can get cheap drug and alcohol rehab centers - Study of Drug-Users Groups By : Mary Anne Winslow
The problem of drug abusing is one of the most vital issues that needs much of public and governmental attention to be paid to. Until we study the reasons that cause people to use drugs and keep abusing them we will not be able to give any assistance to them. We also need to learn to help them to reintegrate back into society successfully after they get rid of their dependence on drugs. It is essential to study the drug users' attitudes, life style and opinions to be able to provide necessary help to them and prevent others from abusing drugs - PBMI Webcast Will Help Employers Actively Manage Specialty Drug Coverage By : Health News
The steps employers should be taking to better manage specialty drug coverage will be discussed in a Webcast hosted by the Pharmacy Benefit Management Institute (PBMI) from 2:00 to 3:30 p.m. Eastern Daylight Time on October 11, 2006. Webcast registration is available at www.pbmi.com. - Adolescent Stages of Addiction By : Wendy McLellan
Every year one of the leading causes of death by adolescents is addiction and drug overdoses. The earlier you can catch these symptoms, the better chance the adolescent has of a full recovery. Learn the signs and try to catch them early. - Thousands of People have a Problem with Drugs By : Jarl Jacobsen
The goal of drug detox to get the toxins accumulated from the drugs out of the body. The first step in the process of detox is withdrawal. - Substance Addiction and Rehabilitation By : David Snape
One thing is for sure, if you don't take action, the addiction will rule your destiny until you reclaim it. - Auriga Files Key Patent on Advanced Drug-Delivery Method to Expand Company’s New Drug Development By : Health News
Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company driving high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, today announced the filing of a new provisional patent application for colonic delivery of corticosteroids that further expands the Company’s proprietary technology portfolio. - Alcohol: The Most Used And Abused Drug By Teenagers By : Angie Lewis
According to the National Institute on Alcohol Abuse and Alcoholism, June 1997, alcohol is the leading cause of death among teenagers. Teenage drinking contributes to the high rate of teenage car crashes, traumatic injuries, suicide and date rape. Alcohol is by far the most used and abused drug among America’s teenagers today. According to a national survey, nearly one third (31.5%) of all high school students reported hazardous drinking of five or more drinks in one setting.Twenty million American’s are alcoholics, and the children of these alcoholics are likely to inherit the disease. More than 40% of those who start drinking at age fourteen or younger become alcoholics. The problem I see is the lack of knowledge about alcoholism being an inherited disease. Children of alcoholics are four times more likely than other children to become alcoholics, according to the American Academy of Child & Adolescent Psychiatry. - Understanding the Issues Relating to Chirality in Drug Research By : Health News
Research and Markets (http://www.researchandmarkets.com/reports/c43175) has announced the addition of Chirality in Drug Research to their offering.
This practice-oriented handbook highlights all issues relating to chirality of pharmaceuticals, from challenges in the synthesis of these complex molecules to analytical techniques to aspects of pharmacology and drug development. It is highly useful for every medicinal chemist involved in small molecule drug development. - Controlling Antibiotics And Antibiotic Resistance In Hospitals By : Drug Resistance News
In one of the first national studies on guidelines that control antibiotics and antibiotic resistance in hospitals, researchers from the Indiana University School of Medicine, the Regenstrief Institute, Inc. and the Richard Roudebush Veterans Administration Medical Center report that hospitals that follow national guidelines on controlling antibiotic use have lower rates of antibiotic resistance. - Immtech Pharmaceuticals Announces Antimicrobial Pipeline Progress By : Drug Resistance News
Immtech Pharmaceuticals, Inc. (Amex: IMM) announced today progress in development of its preclinical pipeline of antimicrobial drug candidates. In addition to advancing discovery programs in hepatitis C and antifungals, Immtech scientists, in collaboration with its consortium partners, have identified a unique class of compounds with significant activity in treating antibiotic susceptible and antibiotic resistant Gram positive bacterial pathogens, the so-called "super bugs". - Transmission Of Antibiotic-resistant Bacteria Linked To Previous Intensive Care Unit Room Occupants By : Drug Resistance News
Staying in a room in the intensive care unit (ICU) previously occupied by a patient with treatment-resistant bacteria may increase the odds of acquiring such bacteria, according to a report in the October 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. - Phase 1 Clinical Study On Potential Renal Cell Cancer Vaccine Successfully Concluded By Immatics By : Drug Trials News
mmatics, a biopharmaceutical company that specializes in the development of peptide-based immunotherapeutic substances for the treatment of cancers, today announced the successful conclusion of its first Phase 1 clinical study on vaccine IMA901 against renal cell cancer. IMA901 is a combination of 10 different peptide antigens that can be identified as so-called tumor-associated antigens among the majority of renal cell cancer patients. - The Facts Behind Ecstasy Use By : Wendy McLellan
Ecstasy is a widely used illegal drug. Most users believe that recreational use of MDMA is harmless, but nothing could be further from the truth. Unravel some of the studies conducted on MDMA and uncover the truth about the risks associated with it's use. - Can a Cure be Found in Alcohol Rehab? By : Bill Alexander
The Cure for Alcoholism and Drug Abuse has long since been sought. It seemed fleeing at first, almost obtainable and then would slip back into the darkness of oblivion never to see the light of day. It was only with one of the most complete, exhaustive and extensive government studies ever that progress was finally made in discovery of a Cure for Alcoholism and Drug Abuse. It was not from the success of the study that the cure was identified, but only from the failure of the study that progress was made. - Pennsylvania Medical Society Delegates Attending Annual Meeting Will Tackle MRSA By : Drug Resistance News
Members of the Pennsylvania Medical Society attending its annual House of Delegates meeting this year will honor International Infection Prevention Week by learning more on how to reduce methicillin-resistant Staphylococcus aureus (MRSA) transmission. - Killing Resistant Germs By : Drug Resistance News
Although a number of new antibiotics have been discovered in recent decades, our armory against infection is continually being depleted, as our microscopically small enemies are crafty warriors that develop resistance to current antibiotics. Multiresistant bacteria are a big problem, especially in hospitals. - Drug Payment Methodology Task Force Established by the Academy of Managed Care Pharmacy By : Health News
It was announced today that the Academy of Managed Care Pharmacy (AMCP) has initiated an assessment of current payment methodologies used by purchasers such as private health plans and the Medicare and Medicaid programs to pay for prescription drug products. - CombinatoRx to Present at the 2006 BIO Investor Forum By : Health News
CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that Alexis Borisy, President & Chief Executive Officer, is scheduled to provide a corporate update at the upcoming BIO Investor Forum held at the Palace Hotel in San Francisco, CA on October 19, 2006 at 9:40am PT. - Financial Innovations Can Help Produce New Medicines Through Funding of Early-Stage Drug Development By : Health News
Public and private funding in biomedical research has declined – a trend that could jeopardize efforts to find improved treatments for people with life-threatening illnesses.
A new report from the Milken Institute demonstrates that innovative financial tools can lower investor risk and increase the flow of capital to research. - WebAlert: MultiCell Technologies to Release CEO Interview to Discuss Progress in Business By : Health News
MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on modulation of the immune system, will release an audio interview with Dr. Stephen Chang, President and Chief Executive Officer of MultiCell, on Monday, October 16, at 12 noon Eastern. - Drug Rehab And Alcohol Rehabilitation Programs By : Michael Rad
Drug rehabilitation is a program in more steps that help drug addicts return to a normal life helping them to withdraw from chemical dependency. What is crucial for a successful drug rehab is to choose the best program, presupposing the best treatment that fits your profile. - Gene Logic Enters into Agreement with Lilly to Discover New Development By : Health News
Gene Logic Inc. (NASDAQ: GLGC) announced today that it has entered into a drug repositioning and development agreement with Eli Lilly and Company to seek alternative development paths for multiple Lilly drug candidates. All of these drug candidates were discontinued or de-prioritized in clinical trials for reasons other than safety. - Winning FDA Approval for Combination Drugs By : Health News
Preparing for an FDA Advisory Committee hearing is an intensely collaborative process that is magnified enormously when the application is for a combination product,” declared Michael J. Vivion, executive director, ECG, communication consultants to the healthcare industry. Dr. Vivion spoke on October 17 at the 2006 Annual Conference and Exhibition of the Regulatory Affairs Professionals Society (RAPS) held at the Baltimore Convention Center, October 15 – 18. - Indiana University Participates In National Stent Study For Kidney Artery Blockage By : Drug Trials News
Indiana University is recruiting participants for a national study to measure the effectiveness of stents to treat atherosclerotic renal artery stenosis, or narrowing of the kidney arteries. - Drug Addiction or Alcoholism: Which Is Easier To Recover From? By : Jonathan Huttner
Drug addiction and alcoholism, both diseases of the brain which create devastation in the lives of the addict and alcoholic, have often been debated over as to which is easier to recover from. Some say that drug addiction is easier to recover from as alcohol is legal and more prevalent in today's society, thus creating greater opportunity for relapse in the case of the alcoholic. The other side of this debate would be that illegal drugs and the addict's "connection" are still present, prescription medication is being prescribed in ever increasing amounts, not to mention, the internet has now made the purchase of narcotics easier than ever before. - Drug Rehab, Recovery and the Pink Cloud By : Jonathan Huttner
Is it a myth or reality, fact or fiction? The "pink cloud" is an experience common to almost everyone that seeks recovery from drug addiction or alcoholism. - Zacks Analyst Interview Highlights: Wal-Mart, Walgreen, CVS and Rite Aid. By : Health News
Zacks.com releases the latest Analyst Interview. Today’s interview is with senior analyst Steven Ralston, who discusses Wal-Mart (NYSE: WMT), Walgreen (NYSE: WAG), CVS (NYSE: CVS) and Rite Aid (NYSE: RAD). - Chemists Decode Bacterial "Conversations" In Effort To Block Deadly Infections By : Drug Resistance News
Eavesdropping can sometimes be a good thing. Researchers are learning how to listen to a wide range of bacterial conversations -- the chemical signals bacteria use to communicate with each other -- in an effort to design new compounds to thwart deadly infections, particularly those involved in the growing problem of antibiotic resistance, according to an article scheduled for the Oct. 23 issue of Chemical & Engineering News, ACS' weekly newsmagazine. - Drugs Approved for the Treatment of Leukemia: a Historical Perspective By : Health News
Research and Markets (http://www.researchandmarkets.com/reports/c43880) has announced the addition of “Hematological Cancers - A Therapeutic & Competitive Insight” to their offering. - Drug Detox: A Brief Overview By : Sandra Kim Leong
Usually drug detox centers give simple medication to the patient. This keeps the patient to get away from the withdrawal, which is the physiological and mental readjustment occurring due to the discontinuation of the use of drug or any other addictive substances. Withdrawal is considered as the first steps of drug detox. - Useful Hints On Drug And Alcohol Rehabilitation Centers By : Ras Reed
This article briefly describes what you should look out for when searching for the right drug and alcohol rehab centers. - Anonymous Intervention By : Mikki Alhart
Do you know someone with a substance abuse problem and don't know how to approach them? We have an answer - Developing Better Methods Of "Blinding" Doctors And Patients In Clinical Trials By : Drug Trials News
When trials are carried out to assess the effectiveness of a drug, it is an important to have a control group of patients who are not given the drug. Neither the researchers nor the patients should know who is in the treatment group and who is in the control group. In other words they should be 'blinded'. - Why You Need Drug Or Alcohol Rehab Centers By : Ras Reed
Do you really think you need to check into a drug or alcohol rehab center? This article will help you decide - Looking For Los Angeles Drug Rehab Centers By : Ras Reed
This article gives you reputable Los Angeles drug rehab centers - The Truth About Alcohol And Drugs - You Don't Need Them By : Eva Fry
Allow your own abilities to grow so you can become the great person God intended you to be. Don't cloud your mind and future with alcohol and drugs. YOU DON'T NEED THEM! Instead, develop the natural gifts and talents God blessed you with and become a WINNER! - Leading UK-Based Clinical Trial Support Organization Selects DATATRAK EClinical(TM) By : Drug Trials News
DATATRAK International, Inc. (Nasdaq: DATA), a technology company focused on global eClinical solutions for the clinical trials industry, today reported that The Medical Research Network, part of the Healthcare at Home group of companies, that offers a unique portfolio of clinical trials services including the unparalleled ability to administer therapies in the home, has selected the Company's eClinical suite as their preferred enterprise information platform for their clinical trial offerings. - Two-component Lantibiotic With Therapeutic Potential Discovered By Scientists By : Drug Resistance News
The discovery and preparation of a naturally occurring antibiotic could open the door to new therapeutic drugs for treating nasty infections. - Preventing Abuse of Prescription Drugs and Pain Medications By : Ramy D.
Relieving pain from a patient while steering clear from the possible addiction to pain killers has become the specific problem health care provider constantly fight. This article explores the issue and what you can do as a patient or doctor to understand the risks of pain killers. - Useful Guide On Drug Rehab Centers By : Ras Reed
Before checking into any drug rehab center, make sure you have the tips outlined in this article at the back of your mind. - Ondansetron - A Breakthrough In Alcohol Treatment Medication By : David Richards
Originally, Ondansetron is a drug used to stop nausea that has been found to be effective against drinking. Studies conducted from the University of Texas Health Science Center show that this medicine helps those who develop alcoholism before the age of 25 to quit drinking and keep off the bottle. - Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System By : Health News
Professor Ian Meredith, M.D., Monash Medical Centre, Melbourne, Australia, today presented positive preliminary results from the Medtronic RESOLUTE clinical trial, a first-in-man study evaluating the new Endeavor RESOLUTE zotarolimus-eluting stent system. Four-month angiographic and clinical results reinforce that zotarolimus continues to be a very potent drug in preventing restenosis, even in challenging patient populations. - ChloraPrep® For MRSA And Other Bacterial Infections Launched In UK By : Drug Resistance News
A 'revolutionary' skin preparation system called for by NHS staff and recommended by the Health Protection Agency (HPA) in the fight against MRSA and other bacteria responsible for bloodstream infections, is now available in the UK. - MRSA Vaccine Shows Promise In Mouse Study By : Drug Resistance News
By combining the four bacterial surface proteins that generate the strongest immune response in mice, researchers at the University of Chicago have created a vaccine that significantly protects immunized animals from multiple disease-causing, drug-resistant strains of Staphylococcus aureus, the most common cause of hospital-acquired infections and a rapidly spreading source of community-associated illness. - Revamping the U.S. Drug Safety System: Cleveland Clinic’s Steven Nissen By : Health News
The Food and Drug Administration’s (FDA) approach to drug safety is headed for significant changes in the wake of several high-profile drug withdrawals, critiques of the advisory committee process, and pending legislation to revamp its review procedures. These changes will have a lasting impact on the companies that develop and market regulated drugs. - ABMC Announces Expansion of Sales of Its Rapid Drug Screen® in Spain By : Health News
American Bio Medica Corporation (NASDAQ: ABMC) has announced today that they have received an initial order of 80,000 units for its Rapid Drug Screen (RDS®) from Diagnosticos Rapidos De Espańa of Sevilla, Spain, ABMC’s distributor in Spain since June 2004. The value of the order exceeds $400,000 (USD). - "Super Bug" Scares - Straight Facts About Antibiotic Resistance By : Drug Resistance News
With recent news about "super bugs," you may wonder if antibiotics are still effective, and whether they will work for you when you need them. You're not alone - there is a lot of confusion about antibiotics - what they do and don't treat, and why they sometimes stop working. It is important to know that antibiotics are effective only if they are prescribed and taken correctly. - Drug Rehab or Addiction Treatment - What Is the Difference? By : Jonathan Huttner
Recently a topic of conversation centered on whether there is a difference between a drug rehab and an addiction treatment center. As surprised as people were at the question, it made all of us realize those individuals without knowledge of the addiction treatment business or who have not been in addiction treatment themselves, might be easily confused. - Relapse Prevention and the Pink Cloud By : Jonathan Huttner
The "pink cloud" is best described as a period of time where the addict or alcoholic experiences a reprieve from the struggles associated with early recovery. These struggles are generally associated with the feelings of depression, anger, resentment, self pity and the realization of where their drug addiction or alcoholism has taken them. - AMRI Launches Interactive Drug Discovery Tool, ''AMRIDirect'' By : Health News
Albany Molecular Research, Inc. (NASDAQ: AMRI) today announced the launch of AMRIDirect (www.amridirect.com), a searchable, online database of drug-like compounds for use in drug discovery. - Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 to Be Presented at Upcoming ACR Meeting By : Health News
CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that posters regarding its product candidates, CRx-102 and CRx-139 will be presented at the American College of Rheumatology (ACR) meeting November 10-15, 2006 in Washington, DC. - Genetic Engineering News Reports on Efforts to Foil Counterfeit Drugs By : Health News
Biotech and pharmaceutical firms are becoming increasingly worried over the issue of counterfeit drugs, reports Genetic Engineering News (GEN) (www.genengnews.com). Their concerns are being fueled by higher threat levels, the value of the products involved, and the number of counterfeit drugs being produced, according to an article in the November 1 issue of GEN. - MRSA Toxin Acquitted: Study Clears Suspected Key To Severe Bacterial Illness By : Drug Resistance News
Researchers who thought they had identified the bacterial perpetrator of the often severe disease caused by community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) had better keep looking: Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have exonerated a toxin widely thought to be the guilty party. - Enzyme Inhibitor Produces Stable Disease In Patients With Advanced Solid Cell Cancers By : Drug Trials News
Preliminary trials of a MEK enzyme inhibitor have shown that it is capable of producing long-lasting stable disease in patients with advanced solid cancers. Tests showed that the drug inhibited key targets in the patients' tumours, and now it is being tested in phase II clinical trials. - Addiction Treatment for Gay Men and Women in a Gay Drug Rehab By : Jonathan Huttner
Addiction treatment and therapy for gay men and women in a gay drug rehab may differ from rehab to rehab. Don't be afraid to ask questions to see which drug rehab best meets your needs. - Crystal Meth and the Gay Community By : Jonathan Huttner
Crystal Meth is a drug that has infected all of America, but especially the gay community. With increased use of crystal meth comes an increased spread of HIV and an evergrowing need for drug rehab.
|
